Ashton Thomas Securities’s Gentex GNTX Stock Holding History

Ashton Thomas Securities’s Portfolio GNTX Stock Details GNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,082	Closed	-$692K	–	268
2024 Q4	$692K	Sell	24,082 -19,694	-45%	-$589K	0.19%	126
2024 Q3	$1.3M	Buy	43,776 +4,080	+10%	+$127K	0.25%	93
2024 Q2	$1.33M	Buy	+39,696	New	+$1.37M	0.32%	81

Other funds holding GNTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ashton Thomas Securities's GNTX Position: Q1 2025 in Review

Ashton Thomas Securities sold out of Gentex (GNTX) in Q1 2025, closing a stake of 24,082 shares — an estimated $692K sold.

Ashton Thomas Securities first reported a position in GNTX in Q2 2024 and held it in 3 quarters. The position peaked at $1.33M in Q2 2024. 517 funds tracked by Wall St. Rank hold GNTX as of Q1 2025.

Ashton Thomas Securities reported no remaining Gentex position as of Q1 2025 after selling out during the quarter.
Ashton Thomas Securities sold 24,082 Gentex shares in Q1 2025, an estimated $692K.
Ashton Thomas Securities first reported a position in Gentex in Q2 2024 and held it in 3 quarters.
Ashton Thomas Securities's Gentex position peaked at $1.33M in Q2 2024.
517 funds tracked by Wall St. Rank held Gentex as of Q1 2025.

Based on Ashton Thomas Securities's 13F filing for Q1 2025, filed 15 May 2025.